Nasdaq Stock News

9 Meters Biopharma (NASDAQ:NMTR) announced its quarterly earnings results on Sunday. The company reported ($0.05) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.04) by ($0.01), Fidelity Earnings reports. Shares of NASDAQ NMTR traded down $0.03 during trading hours on Tuesday, hitting $1.10. 1,607,804 shares of the stock were exchanged, compared to []

Centessa Pharmaceuticals (NASDAQ:CNTA) announced its quarterly earnings results on Sunday. The company reported ($0.45) earnings per share (EPS) for the quarter, beating the Zacks consensus estimate of ($0.55) by $0.10, MarketWatch Earnings reports. Shares of NASDAQ:CNTA traded up $0.62 on Tuesday, reaching $12.54. The company had a trading volume of 137,684 shares, compared to its []

Intuit (INTU) Readies to Report Q1 Earnings: What''s in Store? Nasdaq

Credit Suisse Lists UPS as a Conviction Play Nasdaq

Banking stocks drag Australia shares lower on inflation anxiety Nasdaq

Buy This Top Tech Stock at New Highs and Hold for Years? Nasdaq

Lower volumes compared to ProShares were expected, but Van Eck hopes its lower fees can give it an edge over competitors. The VanEck Bitcoin Strategy ETF (XBTF) closed its first day of trading on Nov. 16 with "respectable" trading volume, but one that pales in comparison to similar launches. Bitcoin futures ETFs provide investors exposure to potential future prices of Bitcoin without forcing them to hold any Bitcoin themselves. At market close on the Chicago Board of Exchange (CBOE), XBTF had accumulated around $9.5 million in assets under management (AUM), and saw around $4.6 million in daily trading volume according to investing.com . This is just a fraction of the first-day trading volume of $1 billion the ProShares Bitcoin Strategy (BITO) enjoyed on Oct. 19 on NYSE. BITO has since reached the top 2% of all ETFs by total trading volume. Tommy Horan, Head of Corporate Partnerships at Australian exchange Swyftx said that it had been a pretty subdued launch but VanEck wont be too worried.

Cocrystal Pharma (NASDAQ:COCP) posted its quarterly earnings data on Sunday. The company reported ($0.04) earnings per share for the quarter, hitting the consensus estimate of ($0.04), MarketWatch Earnings reports. NASDAQ COCP traded down $0.02 on Tuesday, reaching $0.89. The companys stock had a trading volume of 465,674 shares, compared to its average volume of 6,731,909. []

Liminal BioSciences (NASDAQ:LMNL) posted its earnings results on Monday. The company reported $2.74 EPS for the quarter, topping the Thomson Reuters consensus estimate of ($0.34) by $3.08, Fidelity Earnings reports. Liminal BioSciences had a negative return on equity of 457.84% and a negative net margin of 6,157.81%. Shares of NASDAQ:LMNL remained flat at $$1.60 during []

Avenue Therapeutics (NASDAQ:ATXI) released its quarterly earnings results on Sunday. The company reported ($0.05) earnings per share (EPS) for the quarter, hitting the Thomson Reuters consensus estimate of ($0.05), Fidelity Earnings reports. Shares of NASDAQ:ATXI traded down $0.01 on Tuesday, hitting $1.37. The companys stock had a trading volume of 185,269 shares, compared to its []

PHILADELPHIA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Armada Acquisition Corp. I (NASDAQ GM: AACIU) (the Company) announced today that, commencing November 16, 2021, holders of the 15,000,000 units sold in the Companys initial public offering may elect to separately trade shares of the Companys common stock and warrants included in the units. The shares of common stock and warrants that are separated will trade on the Nasdaq Global Market (Nasdaq) under the symbols AACI and AAICW, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on Nasdaq under the symbol AACIU. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into shares of common stock and warrants.

(RTTNews) - After ending the previous session roughly flat, stocks moved mostly higher during trading on Tuesday. The major averages all moved to the upside on the day, although buying interest waned as the trading day progressed. The Dow and the S&P 500 pulled back well off their highs in late-day trading, while the tech-heavy Nasdaq remained

NANPING, China, Nov. 16, 2021 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) announced today that the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") on November

Abeona Therapeutics (NASDAQ:ABEO) released its quarterly earnings results on Sunday. The biopharmaceutical company reported ($0.16) earnings per share for the quarter, hitting the Zacks consensus estimate of ($0.16), Fidelity Earnings reports. Shares of NASDAQ:ABEO opened at $0.91 on Tuesday. The company has a market cap of $92.18 million, a P/E ratio of -1.57 and a []

To NASDAQ OMX Copenhagen